| Name | Title | Contact Details |
|---|
SeaKay is a San Francisco, CA-based company in the Business Services sector.
Senergy Petroleum leads the Southwest and Rockies petroleum industry. We prioritize innovation to stay competitive and attract the best professionals to shape the industrys future. Our company culture has always been based on hiring the best people and allowing them to build and rebuild the industry. Our technology-driven fleet, high-quality products, and cutting-edge services make Senergy Petroleum powerful enough to handle your needs, and local enough to care. Our technology-driven fleet, high-quality products and cutting-edge services make Senergy Petroleum powerful enough to handle your needs, and local enough to care.
Maxim Security Inc is a Kansas City, MO-based company in the Business Services sector.
Malbar Vision Ctr is a Omaha, NE-based company in the Business Services sector.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.